79720-9
CYP2B6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
Active
Term Description
The CYP2B6 gene product metabolic activity interpretation is determined by the reporting lab and returned with the structured test results. The Preferred Answer list associated with this term is based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for reporting CYP2B6 gene product metabolic activity (phenotype), which apply to both genetic and enzymatic assays (this LOINC term represents a genetic assay). This specific interpretation would be considered a separate observation made by the lab in addition to the primary reported results (e.g., genotype or measured activity level) and it could be included with other assay-specific observations, which would ideally support the interpretation value. [https://cpicpgx.org/resources.html]
Source: Regenstrief LOINC
Part Description
LP202923-1 CYP2B6 gene product metabolic activity interpretation
Cytochrome P450-2B6 (CYP2B6; [HGNC Gene ID: 2615]), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism of a number of clinically relevant substrates in current clinical use. Genetic variations in CYP2B6 can affect the response (i.e., efficacy or toxicity) to drugs metabolized by CYP2B6 and selection of alternative dosing or agents may be necessary in individuals with specific CYP2B6 genetic variations. See https://www.pharmgkb.org/gene/PA123for more information and dosing guidelines for drugs impacted by CYP2B6 genetic variation.
Source: Clinical Pharmacogenetics Implementation Consortium
Fully-Specified Name
- Component
- CYP2B6 gene product metabolic activity interpretation
- Property
- Imp
- Time
- Pt
- System
- Bld/Tiss
- Scale
- Ord
- Method
- Molgen
Additional Names
- Short Name
- CYP2B6 gene prod met act imp Bld/T-Imp
- Display Name
- CYP2B6 gene product metabolic activity interpretation Molgen Ql (Bld/Tiss) [Interp]
- Consumer Name Alpha Get Info
- CYP2B6 gene product metabolic activity interpretation, Blood or tissue specimen
Preferred Answer List: LL3856-3
Source: Clinical Pharmacogenetics Implementation ConsortiumAnswer | Code | Score | Answer ID |
---|---|---|---|
Ultrarapid metabolizer | LA10315-2 | ||
Rapid metabolizer | LA25390-8 | ||
Normal metabolizer | LA25391-6 | ||
Intermediate metabolizer | LA10317-8 | ||
Poor metabolizer | LA9657-3 |
Basic Attributes
- Class
- MOLPATH.PHARMG
- Type
- Laboratory
- First Released
- Version 2.54
- Last Updated
- Version 2.67
- Order vs. Observation
- Observation
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Gen CYP2B6 interpretation de la actividad en el metabolismo de fármacos: |
es-MX | Spanish (Mexico) | Interpretación de la actividad metabólica del producto del gen CYP2B6: |
fr-FR | French (France) | CYP2B6 gène activité métabolique interprétation: |
it-IT | Italian (Italy) | Interpretazione dell'attività metabolica del gene CYP2B6: Synonyms: Farmacogenomica Gene CYP2B6 Genetica molecolare Impressione/interpretazione di studio Interpretazione dell''attività metabolica del gene Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & |
nl-NL | Dutch (Netherlands) | CYP2B6-gen product metabole activiteit interpretatie: Synonyms: CYP2B6 gen product metabole activiteit interpretatie molgen |
tr-TR | Turkish (Turkey) | CYP2B6 geni ürünü metabolik aktivite yorumu: |
zh-CN | Chinese (China) | CYP2B6 基因产物新陈代谢活性解释: Synonyms: CYP2B6 基因产物新陈代谢(代谢)活性解释(说明、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=79720-9
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright